Apple outlines ‘Apple Intelligence’ AI plans

Apple has revealed its plans to revamp its operating systems with the integration of generative AI tools such as ChatGPT in a broad offensive to encourage hardware sales.

‘Apple Intelligence’ will soon be available on the latest iPhone models, providing users with the power to enhance writing, create images and summarise telephone calls in an intuitive new operating system.

It is a major move by Apple that will bring AI to the general population in a way that will mean deep integration in everyday mobile phone tasks.

To date, people wanting to deploy the benefits of Generative AI tools such a OpenAI’s ChatGPT would have had to visit the application and use its interface. This technology will now be built into your iPhone and will be utilised with little or no need to move away from the task being undertaken.

The software will initially only be available on iPhone 15 Pro and Pro Max phones – a move clearly designed to encourage users to upgrade their current models.

The plans have been met be a sharp response by Elon Musk who said he will ban his staff from using iPhones claiming a tie-up between Apple and OpenAI will be a ‘security violation’.

“Apple has finally broken its AI silence,” said Matt Britzman, equity analyst, Hargreaves Lansdown

“It’s fair to say Apple was caught off guard by the explosion of activity in the AI space, and it’s turned to a partnership with OpenAI to get its foot in the door. This is a key moment for Apple, which has struggled with innovation of late. Gone are the days when each new iPhone was so jam-packed with new features that consumers felt obligated to upgrade every year, most people probably don’t even know what version they’re using. 

“But this is a marathon, not a sprint. It may be late to the party, but the long-awaited AI strategy could trigger a new surge in demand for the latest handsets. Integrating a third-party tool like ChatGPT finally gets things moving while leaving space to develop internal models over the next few years at much lower costs than the first movers. With generative AI capabilities, Apple will have a fierce combination of deep consumer and developer ecosystems alongside the hardware and software to get AI tools into the hands of everyday consumers.”

Raspberry Pi soars after initial public offering priced at 280p

Raspberry Pi has soared on its London IPO, jumping as much as 39% in early trade on Tuesday.

Raspberry Pi has announced the pricing of its initial public offering at 280p, valuing the company in the region of £541m.

“Raspberry Pi made a storming debut on the UK stock market with its IPO priced at the top end of the range and its shares jumping 39% in the first half hour of trading. UK tech stories are few and far between on the London Stock Exchange so let’s hope the success of Raspberry Pi attracts more peers in the tech sector to the market,” said Russ Mould, investment director at AJ Bell.

The total size of the IPO offer was £166m, but Raspberry Pi will receive just £31m of this because the sale of shares by an existing shareholder made up the lion’s share of the deal.

Retail investors using the Peel Hunt REX platform accounted for £6.8m of the total amount.

“The quality of the interactions during the marketing process has underlined our belief that London has the right calibre and sophistication of investor to support growing, ambitious technology businesses such as Raspberry Pi. The reaction that we have received is a reflection of the world-class team that we have assembled and the strength of the loyal community with whom we have grown,” said Eben Upton, CEO of Raspberry Pi.

“Welcoming new shareholders alongside our existing ones brings with it a great responsibility, and one that we accept willingly, as we continue on our mission to make high-performance, low-cost computing accessible to everyone.”

Mobico Group – Ahead of Today’s AGM The Question Is Whether National Express Is Going Slower?

Later today the Mobico Group (LON:MCG) is holding its AGM to approve its 2023 Report & Accounts.

It was not a good year for the business, with its adjusted pre-tax profits dropping 36.3% to £92.9m (£145.9m) despite group revenues having lifted 12.2% to £3.15bn (£2.81bn), leading to earnings falling some two-thirds from 15.0p to just 4.5p, with a similar cut in dividends to 1.7p (5.0p) per share.

The Business

This group, formerly called National Express, has the vision to be the world’s premier shared mobility operator, with a declared purpose to lead the modal shift from cars to mass transit.

It is a leading international transport operator, diversified internationally and by business area; with operations in North America, continental Europe, the UK and North Africa, operating in more than 50 key cities in 12 countries across the world, employing over 47,700 people in its workforce.

It operates a fleet of some 27,700 vehicles, last year more than 1bn passenger journeys were made on the group’s various services.

Some 67% of the group’s revenue is generated through multi-year contracts, which is an impressive figure.

When announcing the 2023 results in late April, CEO Ignacio Garat stated that:

“Our 2023 results are below the expectations we set ourselves at the beginning of the year.

The delays due to the additional work relating to the German rail business was regrettable but it is now concluded.

Although group revenue growth was encouraging, driven by passenger demand and actions taken to recover inflation, this has not translated into an improvement in reported profitability.

Our focus remains on delivering the benefits of our restructuring programs and in recovering inflationary costs through pricing, while maintaining a relentless focus on the quality of our offering to support growth.

Opportunities remain to create a more appropriate and sustainable cost structure and we will not hesitate to take action where there is a clear strategic and financial benefit.”

Outlook

The group has stated that, based on current market conditions, adjusted operating profit for FY 24 is expected to be within the range of £185m to £205m, with a greater bias to the second half of the year, due to the phasing of cost reduction programmes and the timing of price increases.

Analyst Views

There are some 8 analysts following the group, most of whom rate the group’s shares as a Buy.

The highest Price Objective is 100p, while the lowest is 65p, with the average consensus coming out at 78.88p per share.

Berenberg has recently downgraded because its latest update showed the business had stalled.

The broker’s analyst, Jack Cummings, moved his recommendation from ‘buy’ to ‘hold’ and cut the target price from 100p to 66p.

Noting that the company had again missed expectations, while introducing full-year 2024 guidance that was some 9% below consensus expectations.

“We remain of the view that there are not any imminent refinancing needs, but we can no longer, with confidence, say the shares should be meaningfully higher on a 12-month view based just on organic performance.”

Increasing Short Interest

With some 614m shares in issue, around 70% of its equity is held by the leading ten professional holders.

However, it is worth noting that in the last month there has been an increase in short selling of the group’s stock, with at least 2.74% being contracted lower, with Systematica Investments, GLG Partners and Marshall Wace being the main players.

The group’s shares are currently trading at around 51p, valuing it at £313m.

Helium One Global – Surprise £8.0m Placing By Tanzanian Helium Explorer At 56.5% Discount To Closing Price

After the market closed last night Helium One Global (LON:HE1) announced that it is raising a minimum £8.0m, by way of a cashbox placing of 1,600,000,000 new shares at just 0.50p each, a 56.5% discount to the mid-market closing price of 1.15p.

The company, which is based in Tortola in the British Virgin Islands, is exploring for primary helium in Tanzania, is hoping to use the net proceeds of the Fundraise to complete an Extended Well Test on Itumbula West-1 to evaluate commercial flow rates of helium prior to the development phase.

It will also help to provide additional funds for operational contingency.

The company holds prospecting licences across three distinct project areas, with the potential to become a strategic player in resolving a supply-constrained helium market.

The Rukwa, Balangida, and Eyasi projects are located within rift basins on the margin of the Tanzanian Craton in the north and southwest of the country.

The assets lie near surface seeps with helium concentrations ranging up to 10.6% helium by volume.

The company’s project portfolio includes the Rukwa project consisting of 12 prospecting licenses covering an area of approximately 1,899 sq.km located in southwestern Tanzania; the Eyasi project, which include three prospecting licenses covering an area of approximately 807 sq.km located in north central Tanzania; and the Balangida project comprises one prospecting license covering an area of approximately 259 sq.km located in north central Tanzania.

The company serves the technology, science, medicine, and manufacturing industries. 

The raising was handled by Liberum Capital and Zeus Capital acting Joint Bookrunners   and Axis Capital Markets acting as placing agent.

CEO Lorna Blaisse stated that:

“We are pleased with the response that we have seen during this placing.

These funds will enable us to fulfil the next crucial phase of the Company’s development including the deepening of Itumbula West-1 and the execution of the EWT. Which, combined with the successful award of the Mining License, will allow us to commence development phase for the first helium project in Tanzania.”

Tristel appoints new boss

Disinfection products supplier Tristel (LON: TSTL) has appointed Matt Sassone as its new chief executive. He will replace founder Paul Swinney when he leaves Masimo Corporation in September and already has experience as an AIM boss because he ran LiDCO.
At the end of 2020, Nasdaq-quoted Masimo offered 12p/share in cash for non-invasive hemodynamic monitoring technology developer LiDCO. Masimo is a medical technology company that has commercialised other technologies and it had cash to help the business grow faster. Matt Sassone became senior vice president of marketing at Masimo.
He has been b...

AIM movers: Kropz falls back from high and Arecor Therapeutics requires cash

0

Phosphate producer Kropz (LON: KRPZ) says that it knows no reason for the share price rise this morning. There has been more trading in shares since Friday afternoon and the price has fallen back from above 3p. It is still 47.5% higher at 1.8p.

There was a share price recovery in Clontarf Energy (LON: CLON) after it published 2023 figures. The share price rebounded following the disappointment in Bolivia. It failed to move through to the next stage of the bids for the seven priority salt pans in southern Bolivia. There was nearly £183,000 of cash in the bank at the end of 2023 and a further £700,000 has been raised since. The share price rebounded 32.3% to 0.0205p to a new 2024 high.

Mkango Resources (LON: MKA) subsidiary HyProMag has signed a non-binding memorandum of understanding for its recycling technology with Envipro in Japan and the UK. There will be joint marketing of recycled magnets and a review of NdFeB scrap supply opportunities. There will be recycling trials in the UK and Europe. Mkango Resources owns 79% of HyProMag with CoTec owning the other 21%. The share price improved 22% to 7.5p.

Semiconductors designer Sondrel (LON: SND) has received UK government approval for ROX Equity Partners to subscribe £5.6m for shares at 10p each and convert loans into a further 28.7 million shares also at 10p each. The share price is 16.9% higher at 7.25p.

Mosman Oil and Gas (LON: MSMN) has sold most of its US production assets for $1m in cash and up to $750,000 in contingent consideration over three years depending on the gross production rate averaging more than 250 barrels/day. This provides cash to reinvest in helium assets. The share price rose 10.3% to 0.0375p.

FALLERS

Eurasia Mining (LON: EUA) says that it does not no of any reason for Friday’s jump in the share price. It fell back 39.5% to 2.3p.

Arecor Therapeutics (LON: AREC) requires more cash because it remains loss making. The healthcare company says costs have increased and without savings the existing cash will run out in the third quarter. Revenues should be in line with expectations in 2024, but it does depend on the timing of licence deals. Management wants to conduct an insulin pump study for the ultra-concentrated ultra-rapid acting insulin AT278. This would provide data for potential partners. There is no current commitment to costs for the study. The share price slipped 22% to 124p.

Brave Bison (LON: BBSN) says that The Mission Group (LON: TMG) has been unwilling to engage with it about its potential offer and therefore it will not proceed with a bid. The Mission Group share price fell 11.1% to 24p, while Brave Bison declined 1.02% to 2.425p.  

FTSE 100 falls as France’s Macron announces snap election amid crushing poll results

The FTSE 100 started the week firmly in the red after marathon European elections ended with the announcement of a snap election by the French President who suffered crushing losses to the far-right.

There was a broad increase in support for far-right parties pushing anti-immigration agendas in the European elections, but the centre managed to hang on and retain command of the parliament.

The elections will be a warning to incumbent European political leaders, but the actual results produced little market-moving developments. The biggest shock was Emmanuel Macron’s gamble to call snap elections in an attempt to quell the threat posed to his authority by far-right leader Marine Le Pen. Le Pen’s National Rally party received around 31% of the vote – more than double the votes Macron’s pro-European centrist party.

The snap elections in France won’t unseat Macron himself, and he will continue to be able to rule by presidential decree. The risks stem from a wider leaning towards nationalist parties across Europe that poses a threat to the European project.

This risk was evident in European stocks on Monday, and the FTSE 100 opened up sharply lower with the German DAX and French CAC. The FTSE 100 was down 0.42% at the time of writing.

“Political turmoil in Europe saw the FTSE 100 start the week on the back foot with only a handful of names on the index trading in positive territory,” said AJ Bell investment director Russ Mould.

“An unexpectedly strong showing for far-right parties in European elections in France prompted President Emmanuel Macron to call a snap parliamentary election to be held within the next 30 days. This injects a big dose of the uncertainty which markets hate – with the euro dropping sharply in response to the developments.

“Financial stocks were among the worst performers in London as investors digested the news. Also affecting sentiment were Friday’s better-than-expected US jobs numbers which push back against the narrative that rate cuts are imminent.”

Ashtead

In stock-specific news, Ashtead opened on reports the plant hire company was exploring shifting its primary listing to the US. The move would follow in the footsteps of construction company CRH, who recently ditched London for New York, so the news isn’t a major surprise. However, it will be a major disappointment given the string returns the company has provided investors over the years.

“Ashtead is the twenty-fifth biggest company in the FTSE 100, as measured by its stock market valuation of £24.5 billion, so no-one will want to see the company switch its listing to New York, especially as the firm is just one of eighteen in the UK’s elite index that can point to a record of growing its dividend every year for at least a decade,” says Russ Mould.

“If there is any consolation for the London Stock Exchange, and investors in the UK equity market, Ashtead is unlikely to be leaving because its shares are too cheap relative to its US-quoted peers and rivals for reasons that relate directly to the business rather than optics or the share price.”

Warpaint London – Bullish H1 Trading Update Is Due This Week From Specialist Colour Cosmetics Supplier

Suggesting that Warpaint London (LON:W7L) is a great success story of British enterprise, analysts Darren Shirley and Clive Black at Shore Capital recently upgraded their current year forecasts by some 26% to look for adjusted pre-tax growth to £23.3m, generating 22.6p of earnings per share.

Warpaint sells branded cosmetics, its W7 brand is sold in the UK primarily to major retailers and internationally to local distributors or retail chains.

While Technic, the group’s other main brand, is sold in the UK and continental Europe with a significant focus on the gifting market, principally for high street retailers and supermarkets.

Looking For Strong Multi-Year Growth

The brokers suggest that Warpaint is in the foothills for growth, such foothills have a considerable distance to traverse, and they believe that strong multi-year growth beckons.

Their estimates for the year to end December 2025 are for £116.5m sales, adjusted pre-tax profits of £26.6m, with earnings of 25.8p and a 12.9p dividend per share.

Buy On Any Dips

In late April I wrote that patient investors in Warpaint should look to buy on any dips in the price, and that by doing so they will be onto a winner.

The shares were then 465p and fell back to 455p after news that the group’s CEO and Managing Director were sellers of 3.5m shares a piece, some 9.06% of the equity, ‘in response to strong investor demand’ and wanting to increase the freefloat of its stock and broadening the shareholder register.

Following the Placing at 450p a share, Samuel Bazini, CEO, and Eoin Macleod, MD, were each left with 15.95m shares, representing 20.64% each of the equity.

Share Price Strength Subsequent To Placing

That Placing was substantially oversubscribed and was strongly supported by existing and many new institutional investors.

The group’s shares have been on a gradual ascent since then, topping out at 550p late last week – showing a near-21% gain since the Placing.

The company is due to announce its H1 Trading Update this week.

Chemring Group announces Norwegian missile deal

On Monday, Chemring Group announced a significant long-term agreement between its Norwegian subsidiary, Chemring Nobel, and American aerospace and defense giant Northrop Grumman.

The 15-year partnering deal secures Chemring Nobel as a supplier of HMX, a powerful energetic material used in missile propellants, to Northrop Grumman’s missile programs.

Alongside the 15-year partnership, Northrop Grumman has also placed an $83 million delivery order with Chemring Nobel for HMX supplies. Deliveries under this order will commence in fiscal year 2026 and continue over the following three years. All production will take place at Chemring Nobel’s facility located in Sӕtre, Norway.

“These awards, which illustrate the long-term and valued relationship that we enjoy with Northrop Grumman, support our decision to invest in increasing the capacity of our three energetics businesses over the medium-term, and reinforces Chemring’s position as a key supplier to NATO,” said Michael Ord, Chief Executive of Chemring.

Adriatic Metals – $50m Institutional Placing To Speed Into Silver Production, With Analysts Looking For 50% Share Price Uplift

Just four weeks ago the shares of Adriatic Metals (LON:ADT1) were trading at 253p, by the middle of last week they had fallen back to 196p, before closing on Friday night at a slightly improved 203p.

From this level, market analysts are said to be looking for a recovery back to and then above the 253.50p at which they peaked on 21st May.

The £658m-capitalised Cheltenham-based precious and base metals mining group is the owner of the Vares Silver Operation, which covers a 44sq.km area in Bosnia and Herzegovinia.

It also owns the Raska Zinc-Silver Project in Serbia.

Vares Silver Operation

The world-class Vares site is gaining most investor attention, it contains two advanced exploration deposits, Veovaca and Rupice, which have previously been mined for Lead, Zinc and Barite.   

The company’s exploration programme is focused on the northern and southern extremities of Rupice. 

At the end of May, the company announced that it had agreed a sale of on-specification grade concentrates from Vares.

Currently, it produces high-quality concentrates, with silver content exceeding 2,500g/t and nearly 50% zinc.

It dispatched the first shipment of ore concentrate from the Vares processing plant to the port of Ploče, officially initiating the first sales contract for the concentrate and securing the first million-dollar payment from international buyers.

The company has rapidly achieved significant success with the first shipment of concentrate from the Vareš mine, less than three months after starting production.

Noteworthy too was that it has also reconstructed the railway line connecting Vares with the port of Ploče, enabling ore transport to smelters in Belgium, Norway, Sweden, Spain, and Italy.

With increasing feed tonnage of development ore available, the processing plant will now transition to 24-hour operations in anticipation of first stopes in July.

The company is continuing to ramp up production, with nameplate capacity expected in the final quarter of this year.

CEO Paul Cronin stated that:

“The production of saleable concentrates from the Vares Silver Operation represents a major milestone for the Company and I am very pleased with the progress made by the processing team with the plant producing concentrates with recoveries as expected.

High silver, gold and zinc prices and low treatment charges due to a tight concentrate market are providing positive tailwinds for Adriatic’s free cash flow generation, as we progress towards full production capacity in Q4 of this year.”

Recent $50m Placing

At the same time in late May, Adriatic announced a $50m institutional placement of stock, with the fresh funds expected to boost the company’s balance sheet as it continues to progress the ramp-up and building upon of recent milestones, such as the production of the first saleable concentrate, and then further towards delivering on its mine plan.

Market analysts have Price Objectives of around 300p on the group’s shares.